Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Session: “Gut” to Be Important: The Microbiome and Its Role in Neutropenic Patients Undergoing Chemotherapy and Stem Cell Therapy

3 - Diet, mucus and microbiome in cancer-related neutropenic fever

Wednesday, October 16, 2024
2:40 PM – 3:15 PM US PT
Location: 515 A
Disclosure(s):
Robert Jenq, MD: LISCure Biosciences: Board Member (Ongoing); MaaT Pharma: Board Member (Ongoing); Postbiotics Plus Research LLC: Advisor/Consultant (Ongoing); Prolacta: Advisor/Consultant (Ongoing); Seres Therapeutics: Board Member (Ongoing), Stocks/Bonds (Private Company) (Ongoing)